AllianceBernstein’s Standard BioTools LAB Stock Holding History

AllianceBernstein’s Portfolio LAB Stock Details LAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$404K	Hold	315,690	–	–	﹤0.01%	2746
2025 Q4	$404K	Hold	315,690	–	–	﹤0.01%	2766
2025 Q3	$410K	Hold	315,690	–	–	﹤0.01%	2787
2025 Q2	$379K	Hold	315,690	–	–	﹤0.01%	2802
2025 Q1	$341K	Hold	315,690	–	–	﹤0.01%	2717
2024 Q4	$552K	Hold	315,690	–	–	﹤0.01%	2592
2024 Q3	$609K	Hold	315,690	–	–	﹤0.01%	2567
2024 Q2	$559K	Buy	+315,690	New	+$772K	﹤0.01%	2614
2022 Q2	–	Sell	-98,000	Closed	-$352K	–	3327
2022 Q1	$352K	Buy	98,000 +300	+0.3%	+$1.04K	﹤0.01%	2821
2021 Q4	$383K	Sell	97,700 -53,965	-36%	-$253K	﹤0.01%	2848
2021 Q3	$999K	Buy	151,665 +53,965	+55%	+$355K	﹤0.01%	2493
2021 Q2	$602K	Buy	97,700 +9,400	+11%	+$50.2K	﹤0.01%	2741
2021 Q1	$399K	Hold	88,300	–	–	﹤0.01%	2772
2020 Q4	$530K	Buy	88,300 +16,800	+23%	+$110K	﹤0.01%	2561
2020 Q3	$531K	Sell	71,500 -48,700	-41%	-$336K	﹤0.01%	2500
2020 Q2	$482K	Buy	120,200 +30,400	+34%	+$106K	﹤0.01%	2637
2020 Q1	$228K	Buy	89,800 +15,100	+20%	+$49.6K	﹤0.01%	2743
2019 Q4	$260K	Hold	74,700	–	–	﹤0.01%	2825
2019 Q3	$346K	Sell	74,700 -238,407	-76%	-$1.88M	﹤0.01%	2737
2019 Q2	$3.86M	Buy	313,107 +232,050	+286%	+$2.96M	﹤0.01%	1580
2019 Q1	$1.08M	Buy	81,057 +28,557	+54%	+$301K	﹤0.01%	2215
2018 Q4	$453K	Buy	52,500 +4,500	+9%	+$35.1K	﹤0.01%	2525
2018 Q3	$360K	Buy	48,000 +2,400	+5%	+$17.1K	﹤0.01%	2765
2018 Q2	$272K	Buy	45,600 +2,200	+5%	+$12.5K	﹤0.01%	2851
2018 Q1	$253K	Hold	43,400	–	–	﹤0.01%	2760
2017 Q4	$256K	Buy	43,400 +2,100	+5%	+$11.5K	﹤0.01%	2779
2017 Q3	$208K	Sell	41,300 -4,400	-10%	-$18.5K	﹤0.01%	2922
2017 Q2	$185K	Buy	45,700 +7,100	+18%	+$33.7K	﹤0.01%	3008
2017 Q1	$220K	Sell	38,600 -2,400	-6%	-$15.2K	﹤0.01%	2818
2016 Q4	$298K	Sell	41,000 -630	-2%	-$3.96K	﹤0.01%	2747
2016 Q3	$333K	Hold	41,630	–	–	﹤0.01%	2667
2016 Q2	$376K	Buy	41,630 +3,200	+8%	+$30.1K	﹤0.01%	2619
2016 Q1	$310K	Sell	38,430 -1,400	-4%	-$10.1K	﹤0.01%	2572
2015 Q4	$431K	Sell	39,830 -3,400	-8%	-$33.4K	﹤0.01%	2504
2015 Q3	$351K	Sell	43,230 -2,370	-5%	-$37.3K	﹤0.01%	2615
2015 Q2	$1.1M	Buy	45,600 +3,700	+9%	+$117K	﹤0.01%	2217
2015 Q1	$1.76M	Hold	41,900	–	–	﹤0.01%	1822
2014 Q4	$1.41M	Sell	41,900 -2,700	-6%	-$76.5K	﹤0.01%	1976
2014 Q3	$1.09M	Hold	44,600	–	–	﹤0.01%	2141
2014 Q2	$1.31M	Hold	44,600	–	–	﹤0.01%	2078
2014 Q1	$1.97M	Hold	44,600	–	–	﹤0.01%	1732
2013 Q4	$1.71M	Buy	44,600 +4,100	+10%	+$121K	﹤0.01%	1829
2013 Q3	$889K	Sell	40,500 -186,114	-82%	-$3.66M	﹤0.01%	2190
2013 Q2	$3.96M	Buy	+226,614	New	+$3.98M	﹤0.01%	1127

Other funds holding LAB

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

MCO

MAK Capital One New York $679M AUM 29.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

LFCM

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

HBWM

Hollow Brook Wealth Management Katonah, New York $392M AUM 36.68% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

AllianceBernstein's LAB Position: Q1 2026 in Review

AllianceBernstein held its Standard BioTools (LAB) position steady in Q1 2026 at 315,690 shares worth $404K. The position accounts for ﹤0.01% of the portfolio, ranked #2746.

AllianceBernstein first reported a position in LAB in Q2 2013 and has held it in 44 quarters since. The position peaked at $3.96M in Q2 2013. 155 funds tracked by Wall St. Rank hold LAB as of Q1 2026.

AllianceBernstein held 315,690 shares of Standard BioTools worth $404K as of Q1 2026.
AllianceBernstein left its Standard BioTools share count unchanged in Q1 2026.
Standard BioTools made up ﹤0.01% of AllianceBernstein's portfolio in Q1 2026, its #2746 holding.
AllianceBernstein first reported a position in Standard BioTools in Q2 2013 and has held it in 44 quarters since.
AllianceBernstein's Standard BioTools position peaked at $3.96M in Q2 2013.
155 funds tracked by Wall St. Rank held Standard BioTools as of Q1 2026.

Based on AllianceBernstein's 13F filing for Q1 2026, filed 15 May 2026.